Thomas Lingelbach

CEO & Chair at Valneva

Previous CEO of Intercell, Managing Director for Novartis Vaccines & Diagnostics Germany, Vice President of Global Industrial Operations at Chiron Vaccines, more than 25 years in the vaccine industry.

Location

Vienna, Austria

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Valneva

2 followers

Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva has leveraged its expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19.


Industries

Employees

501-1,000

Links